ISRG Quote, Financials, Valuation and Earnings

Boston Scientific has a net margin of 30.99% compared to Intuitive Surgical's net margin of 14.45%. Intuitive Surgical's return on equity of 15.82% beat Boston Scientific's return on equity of 9.57%.

Intuitive Surgical has a consensus price target of $573.63, signalling upside risk potential of 6.92%. On the other hand Boston Scientific has an analysts' consensus of $116.12 which suggests that it could grow by 12.89%. Given that Boston Scientific has higher upside potential than Intuitive Surgical, analysts believe Boston Scientific is more attractive than Intuitive Surgical.

Intuitive Surgical has a beta of 1.697, which suggesting that the stock is 69.708% more volatile than S&P 500. In comparison Boston Scientific has a beta of 0.685, suggesting its less volatile than the S&P 500 by 31.536%.

Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Intuitive Surgical pays -- of its earnings as a dividend. Boston Scientific pays out -- of its earnings as a dividend.

Intuitive Surgical quarterly revenues are $2.3B, which are smaller than Boston Scientific quarterly revenues of $4.7B. Intuitive Surgical's net income of $698.4M is higher than Boston Scientific's net income of $674M. Notably, Intuitive Surgical's price-to-earnings ratio is 78.67x while Boston Scientific's PE ratio is 75.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 22.35x versus 8.72x for Boston Scientific. Usually stocks with elevated PS ratios are considered overvalued.

Integra Lifesciences Holdings has a net margin of 30.99% compared to Intuitive Surgical's net margin of -6.61%. Intuitive Surgical's return on equity of 15.82% beat Integra Lifesciences Holdings's return on equity of -1.88%.

Intuitive Surgical has a consensus price target of $573.63, signalling upside risk potential of 6.92%. On the other hand Integra Lifesciences Holdings has an analysts' consensus of $17.38 which suggests that it could grow by 41.84%. Given that Integra Lifesciences Holdings has higher upside potential than Intuitive Surgical, analysts believe Integra Lifesciences Holdings is more attractive than Intuitive Surgical.

Intuitive Surgical has a beta of 1.697, which suggesting that the stock is 69.708% more volatile than S&P 500. In comparison Integra Lifesciences Holdings has a beta of 1.268, suggesting its more volatile than the S&P 500 by 26.765%.

Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Integra Lifesciences Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Intuitive Surgical pays -- of its earnings as a dividend. Integra Lifesciences Holdings pays out -- of its earnings as a dividend.

Intuitive Surgical quarterly revenues are $2.3B, which are larger than Integra Lifesciences Holdings quarterly revenues of $382.7M. Intuitive Surgical's net income of $698.4M is higher than Integra Lifesciences Holdings's net income of -$25.3M. Notably, Intuitive Surgical's price-to-earnings ratio is 78.67x while Integra Lifesciences Holdings's PE ratio is 70.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 22.35x versus 0.58x for Integra Lifesciences Holdings. Usually stocks with elevated PS ratios are considered overvalued.

LeMaitre Vascular has a net margin of 30.99% compared to Intuitive Surgical's net margin of 18.39%. Intuitive Surgical's return on equity of 15.82% beat LeMaitre Vascular's return on equity of 13.74%.

Intuitive Surgical has a consensus price target of $573.63, signalling upside risk potential of 6.92%. On the other hand LeMaitre Vascular has an analysts' consensus of $104.50 which suggests that it could grow by 30.2%. Given that LeMaitre Vascular has higher upside potential than Intuitive Surgical, analysts believe LeMaitre Vascular is more attractive than Intuitive Surgical.

Intuitive Surgical has a beta of 1.697, which suggesting that the stock is 69.708% more volatile than S&P 500. In comparison LeMaitre Vascular has a beta of 0.859, suggesting its less volatile than the S&P 500 by 14.076%.

Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LeMaitre Vascular offers a yield of 0.85% to investors and pays a quarterly dividend of $0.20 per share. Intuitive Surgical pays -- of its earnings as a dividend. LeMaitre Vascular pays out 32.65% of its earnings as a dividend. LeMaitre Vascular's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Intuitive Surgical quarterly revenues are $2.3B, which are larger than LeMaitre Vascular quarterly revenues of $59.9M. Intuitive Surgical's net income of $698.4M is higher than LeMaitre Vascular's net income of $11M. Notably, Intuitive Surgical's price-to-earnings ratio is 78.67x while LeMaitre Vascular's PE ratio is 40.54x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 22.35x versus 8.11x for LeMaitre Vascular. Usually stocks with elevated PS ratios are considered overvalued.

Teleflex has a net margin of 30.99% compared to Intuitive Surgical's net margin of 13.56%. Intuitive Surgical's return on equity of 15.82% beat Teleflex's return on equity of 3.41%.

Intuitive Surgical has a consensus price target of $573.63, signalling upside risk potential of 6.92%. On the other hand Teleflex has an analysts' consensus of $157.62 which suggests that it could grow by 25.99%. Given that Teleflex has higher upside potential than Intuitive Surgical, analysts believe Teleflex is more attractive than Intuitive Surgical.

Intuitive Surgical has a beta of 1.697, which suggesting that the stock is 69.708% more volatile than S&P 500. In comparison Teleflex has a beta of 1.170, suggesting its more volatile than the S&P 500 by 17.034%.

Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Teleflex offers a yield of 1.09% to investors and pays a quarterly dividend of $0.34 per share. Intuitive Surgical pays -- of its earnings as a dividend. Teleflex pays out 91.2% of its earnings as a dividend. Teleflex's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Intuitive Surgical quarterly revenues are $2.3B, which are larger than Teleflex quarterly revenues of $700.7M. Intuitive Surgical's net income of $698.4M is higher than Teleflex's net income of $95M. Notably, Intuitive Surgical's price-to-earnings ratio is 78.67x while Teleflex's PE ratio is 39.47x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 22.35x versus 1.94x for Teleflex. Usually stocks with elevated PS ratios are considered overvalued.